Carfilzomib consolidation with cyclophosphamide and dexamethasone conferred noninferior results compared to upfront autologous stem cell transplantation in newly diagnosed, transplant-eligible patients with multiple myeloma.
Recent Content
- Scientists test treatment strategy using ‘glioblastoma on a chip’
- (no title)
- (no title)
- (no title)
- Prostate cancer tool may cut risk for women in radiation therapy
- Predicting adverse events for risk stratification of chemotherapy based stem cell mobilization in multiple myeloma
- (no title)
- (no title)
- (no title)
- FDA OKs multiple myeloma combo for all newly diagnosed patients